Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy. - Wikidata - wikimedia - TriplyDB

Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy.

Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy.

http://www.wikidata.org/entity/Q37630973

about

No immune responses by the expression of the yeast Ndi1 protein in rats Successful amelioration of mitochondrial optic neuropathy using the yeast NDI1 gene in a rat animal model Structural insight into the type-II mitochondrial NADH dehydrogenases Δ9-THC increases endogenous AHA1 expression in rat cerebellum and may modulate CB1 receptor function during chronic use Expression of zinc-deficient human superoxide dismutase in Drosophila neurons produces a locomotor defect linked to mitochondrial dysfunction.Protective Role of rAAV-NDI1, Serotype 5, in an Acute MPTP Mouse Parkinson's Model.Scope and limitations of yeast as a model organism for studying human tissue-specific pathways.Gene-based therapies in Parkinson's disease.Sex-specific differences in mitochondria biogenesis, morphology, respiratory function, and ROS homeostasis in young mouse heart and brain.Mitochondrial involvement in cell death of non-mammalian eukaryotes.Cellular and molecular mechanisms of antioxidants in Parkinson's disease.Kluyveromyces lactis: a suitable yeast model to study cellular defense mechanisms against hypoxia-induced oxidative stress.Mitochondrion-mediated cell death: dissecting yeast apoptosis for a better understanding of neurodegeneration.Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy.Protective Mechanisms of Flavonoids in Parkinson's Disease.Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy.Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD.Testosterone Upregulates the Expression of Mitochondrial ND1 and ND4 and Alleviates the Oxidative Damage to the Nigrostriatal Dopaminergic System in Orchiectomized Rats.Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson's disease.Jia-Jian-Di-Huang-Yin-Zi decoction exerts neuroprotective effects on dopaminergic neurons and their microenvironment.

P2860

Q27317060-352A37E4-FFA8-4FA3-9627-388E2349C988 Q27324143-594DA8D2-6A93-4FD4-94D8-6D8CDA7EDB75 Q27682936-63502A7D-35DB-46BD-B528-B1E4903AC19B Q33723564-0F621D4F-9B8A-49AE-BB8C-6A7A95D7BF42 Q34092213-585AFCDB-0668-4A51-B12C-B24F680D3089 Q34423923-FDA28585-5C6A-49DB-8C3A-FFF6FA93AF28 Q35880992-3B963E91-5FA4-4A22-8134-65409A655EEB Q37506503-27E8AC6F-D221-46E0-9913-79C338C18183 Q37727376-C53A8FE6-DFC6-4544-8BDE-E8ADFA5B6502 Q37800527-9DC89750-A381-48EB-8E6B-049130E045AB Q38021569-A66A1C3E-F059-430E-AB7F-E6B986319C16 Q38038606-6D398594-992A-4C25-8726-C937C882F111 Q38066197-D7EE79E3-D221-4840-AA56-824D96707254 Q38086474-49A45CB0-80B6-4EA1-AC98-40495C95E403 Q38635687-06149C08-E97F-419E-AD5C-4920093AA114 Q41821755-8FA72F81-C308-42FA-89E4-61D281418EC7 Q42580316-946C295C-AFBF-4970-8406-53CBD990E217 Q43375837-C5636BFB-F047-4654-B014-234CFA2EFB64 Q52718634-3278F6CC-E6AC-4EE9-A20F-FDD9C8FA7D93 Q55516053-ED0BFAA3-C394-465E-BB56-7EA1288DFEFE

P2860

Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy.

http://www.wikidata.org/entity/Q37630973

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy.

@en

Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy.

@nl

type

label

Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy.

@en

Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy.

@nl

prefLabel

Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy.

@en

Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy.

@nl

P1433

Q37630973-36AA1D86-1DC7-43D7-819F-AF661BDF7025

P1476

Q37630973-7032EAD5-73BA-4965-AD1F-DBEA6CBD8D41

P2093

Q37630973-013EA6AB-34BF-4A38-AF26-3E25F71001D9

Q37630973-37224DFD-C36E-45FC-8FEE-67E76A54C0D2

Q37630973-A33F64ED-FFE5-445B-94DA-A8B2C1D7A74B

Q37630973-FAE79D26-7C11-4471-A87D-D4EC60EA8406

P2860

Q37630973-15761EB1-F0B1-4863-B50C-3EEAFB0D645D

Q37630973-196A761B-5667-4BCE-B34E-1F428A34EF03

Q37630973-2FC1B761-ADC8-4483-8B04-A7C0C235D152

Q37630973-4166D154-0394-4156-86D0-333DBC6F044F

Q37630973-4B471FC1-911D-4139-9D9D-0BFD750C4B8A

Q37630973-59D1446D-A413-4206-8389-DC62B8CB0AFB

Q37630973-5D80ECB1-77F0-4D0D-8543-6DCE9598CF0E

Q37630973-725CFFE9-D0B4-485C-9648-22AD45C78361

Q37630973-832A7168-5DFA-437D-BB88-FD5DDDEFD778

Q37630973-8AAC90D9-0D4F-45D8-9E3B-43E206B19CA7

P2888

Q37630973-5C4D6EE8-0093-47FF-95CB-FB7E7AF5CC3A

P304

Q37630973-C9FBCF28-AFA4-4FB0-8C86-87601ED0358F

P31

Q37630973-75504470-2E1E-4EA2-BDE1-49374F31A25D

P356

Q37630973-595660A1-25B7-4E98-BE46-3873135D0D3F

P433

Q37630973-74F7647C-AF0E-43CD-AB4D-3905C044FE5E

P478

Q37630973-256FD663-B7A5-4358-8935-4BCAE888ED6E

P577

Q37630973-AC9A8ECC-009F-4424-BED9-D6552134E631

P5875

Q37630973-48BDD8A1-B37B-47D4-BCFE-E0DF861A5397

P698

Q37630973-DDE318A1-B65F-4C13-90FD-04EFC714C041

P921

Q37630973-E032289C-92B6-40D8-9F80-974A264D9AF3

Q37630973-E4392E10-DF98-4C03-98CE-39FD4E7F974D

P932

Q37630973-8B4B3B64-CA1D-416C-91D4-637B26FF2804

P356

S10863-009-9249-Z

P1433

Journal of Bioenergetics and Biomembranes

P1476

Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy.

@en

P2093

Akemi Matsuno-Yagi

http://www.w3.org/2001/XMLSchema#string

Byoung Boo Seo

http://www.w3.org/2001/XMLSchema#string

Mathieu Marella

http://www.w3.org/2001/XMLSchema#string

Takao Yagi

http://www.w3.org/2001/XMLSchema#string

P2860

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease

Mitochondrial dysfunction and oxidative damage in parkin-deficient mice

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled.

The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.

Etiology and pathogenesis of Parkinson's disease.

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.

The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization

P2888

s10863-009-9249-z

P304

493-497

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10863-009-9249-Z

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38081143

http://www.w3.org/2001/XMLSchema#string

P698

19904590

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

2924754

http://www.w3.org/2001/XMLSchema#string